Literature DB >> 2187213

Lorazepam vs. alprazolam in the treatment of panic disorder.

E Schweizer1, R Pohl, R Balon, I Fox, K Rickels, V K Yeragani.   

Abstract

Sixty-seven patients with panic disorder were treated with single-blind placebo for one week before being randomized to 6 weeks of double-blind treatment with either lorazepam or alprazolam. Both drugs showed significant and comparable antipanic efficacy throughout the course of the study. With the exception of sedative effects, both drugs were well-tolerated at a mean daily dose of 7 mg for lorazepam and 3 mg for alprazolam. Lorazepam appeared to be as effective as alprazolam in the acute treatment of panic disorder.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187213     DOI: 10.1055/s-2007-1014489

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  8 in total

1.  Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

2.  Pharmacotherapy for Anxiety Disorders: From First-Line Options to Treatment Resistance.

Authors:  Andrew J Melaragno
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-06-17

Review 3.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

Review 4.  Diagnosis and treatment of agoraphobia with panic disorder.

Authors:  Giulio Perugi; Franco Frare; Cristina Toni
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type.

Authors:  A M Perkins; U Ettinger; K Weaver; A Schmechtig; A Schrantee; P D Morrison; A Sapara; V Kumari; S C R Williams; P J Corr
Journal:  Transl Psychiatry       Date:  2013-04-16       Impact factor: 6.222

6.  Pharmacotherapy of panic disorder.

Authors:  Charles B Pull; Cristian Damsa
Journal:  Neuropsychiatr Dis Treat       Date:  2008-08       Impact factor: 2.570

7.  The Efficacy and Safety of Clonazepam in Patients with Anxiety Disorder Taking Newer Antidepressants: A Multicenter Naturalistic Study.

Authors:  Sheng-Min Wang; Jung-Bum Kim; Jeong Kyu Sakong; Ho-Suk Suh; Kang Seob Oh; Jong-Min Woo; Sang-Woo Yoo; Sang Min Lee; Sang-Yeol Lee; Se-Won Lim; Seong Jin Cho; Ik-Seung Chee; Jeong-Ho Chae; Jin Pyo Hong; Kyoung-Uk Lee
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-05-31       Impact factor: 2.582

Review 8.  Can Interoception Improve the Pragmatic Search for Biomarkers in Psychiatry?

Authors:  Sahib S Khalsa; Rachel C Lapidus
Journal:  Front Psychiatry       Date:  2016-07-25       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.